A RAPID AND COST EFFECTIVE UV SPECTROPHOTOMETRIC METHOD DEVELOPMENT AND VALIDATION FOR THE QUANTITATIVE ESTIMATION OF INDINAVIR SULPHATE IN CAPSULES

Authors

  • N. Lakshmi Prasanna Department of Pharmaceutical analysis and Quality Assurance, Vijaya college of pharmacy, Munaganur (village), Hayathnagar (mandal), Hyderabad 501511, India
  • K. Rajitha Department of Pharmaceutical analysis and Quality Assurance, Vijaya college of pharmacy, Munaganur (village), Hayathnagar (mandal), Hyderabad 501511, India
  • G. Vasundhara Department of Pharmaceutical analysis and Quality Assurance, Vijaya college of pharmacy, Munaganur (village), Hayathnagar (mandal), Hyderabad 501511, India
  • A. Ashok Kumar Department of Pharmaceutical analysis and Quality Assurance, Vijaya college of pharmacy, Munaganur (village), Hayathnagar (mandal), Hyderabad 501511, India

Keywords:

UV, Indinavir sulphate, Method development, Validation

Abstract

Objective: To develop a cheap and rapid UV spectrophotometric method for the quantitative estimation of Indinavir sulphate (400mg) in capsules and validate as per ICH guidelines.

Methods: The optimized method uses a diluent 100% potassium dihydrogen ortho phosphate buffer (pH 3.0) for the estimation of assay of Indinavir sulphate whose lmax is 259 nm.

Results: The developed method resulted in Indinavir sulphate exhibiting linearity in the range 20-80 μg/ml. The precision is exemplified by relative standard deviation of 1.49%. Percentage Mean recovery was found to be in the range of 98â€102, during accuracy studies. The limit of detection (LOD) and limit of quantitiation (LOQ) were found to be 5 mg/ml, and 16.27 mg/ml respectively.

Conclusion: A cheap and rapid UV spectrophotometric method was developed and validated for the quantitative estimation of Indinavir sulphate in capsules as per ICH guidelines and hence it can be used for the routine analysis in various pharmaceutical industries.

Downloads

Download data is not yet available.

References

Vacca JP, Dorsey BD, Schleif WA, Levin RB, McDaniel SL, Darke PL, Zugay J, Quintero JC, Blahy OM, Roth E, Sardana VV, Schlbach AJ, Graham PI, Condra JH, Gotlib L, Holloway MK, Lin J, Chen IW, Vastag K, Ostovic D, Anderson PS, Emini EA, Huff JF. L-735,524:an orally bioavailable human immunodeficiency virus type 1 protease inhibitor. Proc Natl Acad Sci USA 1994;91(9):4096-4100.

Yeh KC, Deustsch PJ, Haddix H, Hesney M, Hoagland V, Ju WD, Justice SJ, Osbournem B, Sterrett AT, Stone JA, Woolf E, Waldman S. Single-Dose Pharmacokinetics of Indinavir and the Effect of Food. Antimicrob Agents Chemother 1998;42(2):332-338.

Patrick AK, Potts KE. Protease Inhibitors as Antiviral Agents. Clin Microbiol Rev 1998;11(4):614-627

Woolf E, Haddix HM, Matuszewski B. Determination of an in vivo metabolite of a human immunodeficiency virus protease inhibitor in human plasma by high-performance liquid chromatography with tandem mass spectrometry. J Chromatogr A 1997;762(1-2):311-319.

Burger DM, de Graaff M, Wuis EW, Koopmans P, Hekster YA. Determination of Indinavir, an HIV-protease inhibitor, in human plasma by reversed-phase high-performance liquid chromatography. J Chromatogr B Biomed Sci Appl 1997;703:235-241.

Dailly E, Thomas L, Kergueris MF, Joillet P, Bourin M. High-performance liquid chromatographic assay to determine the plasma levels of HIV-protease inhibitors (amprenavir, indinavir, nelfinavir, ritonavir and saquinavir) and the non-nucleoside reverse transcriptase inhibitor (nevirapine) after liquid–liquid extraction. J Chromatogr B Biomed Sci Appl 2001;758:129-135.

Foisy ML, Sommadossi JP. Rapid quantification of indinavir in human plasma by high-performance liquid chromatography with ultraviolet detection. J Chromatogr B Biomed Sci Appl 1999;721(2);239-247.

Jayewardene AL, Zhu F, Aweeka FT, Gambertoglio JG. Simple high-performance liquid chromatographic determination of the protease inhibitor Indinavir in human plasma. J Chromatogr B Biomed Sci Appl 1998;707(1-2):203-211.

Jayewardene A, Kearney B, Stone JA, Gambertoglio JG, Aweeka FT. An LC-MS-MS method for the determination of Indinavir, an HIV-1 protease inhibitor, in human plasma. J Pharm Biomed Anal 2001;25(2):309-317.

10.Rose MJ, Merschman SA, Eisenhandler R, Woolf EJ, Yeh KC, Lin L, Fang W, Hsieh J, Braun MP, Gatto GJ, Matuszewski BK. High-throughput simultaneous determination of the HIV protease inhibitors Indinavir and L-756423 in human plasma using semi-automated 96-well solid phase extraction and LC-MS/MS. J Pharm Biomed Anal 2000;24(2):291-305.

Elisabete AP, Gustavo AM, Marina FMT. Development and validation of a capillary electrophoresis method for the determination of sulphate in Indinavir sulphate raw material. Journal of the Brazilian Chemical society 2006;17(2);251-256.

Johnson BD, Howard A, Varsolona R, McCauley J, Ellison DK. Indinavir. Anal. Prof. Drug Substances 1999;26:319-357.

United States Pharmacopeial Convention;Pharmacopeial Forum, Rockville, MD 2000;26:1638.

Erk N. Spectrophotometric determination of Indinavir in bulk and pharmaceutical formulations using bromocresol purple and bromothymol blue. Pharmazie 2004;59(3):183-186.

International Conference on Harmonization of Technical Requirements for Registration of Pharmaceuticals for Human use. Validation of Analytical Procedures:Text and Methodology ICH Q2 (R1). 2005.

Published

01-07-2014

How to Cite

Prasanna, N. L., K. Rajitha, G. Vasundhara, and A. A. Kumar. “A RAPID AND COST EFFECTIVE UV SPECTROPHOTOMETRIC METHOD DEVELOPMENT AND VALIDATION FOR THE QUANTITATIVE ESTIMATION OF INDINAVIR SULPHATE IN CAPSULES”. International Journal of Pharmacy and Pharmaceutical Sciences, vol. 6, no. 7, July 2014, pp. 504-7, https://mail.innovareacademics.in/journals/index.php/ijpps/article/view/1749.

Issue

Section

Original Article(s)

Most read articles by the same author(s)

1 2 3 > >>